Ikena Oncology (IKNA) SEC Filings & 10K Form $1.50 -0.01 (-0.66%) Closing price 01/17/2025 04:00 PM EasternExtended Trading$1.51 +0.01 (+0.67%) As of 08:00 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share SEC Filings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrends Recent Ikena Oncology SEC Filings All Filing Types 1 10 10-D 10-K 10-M 10-Q 11-K 12b-25 13F 13H 144 15 15F 17-H 18 18-K 19b-4(e) 19b-4 19b-7 1-A 1-E 1-K 1-N 1-SA 1-U 1-Z 20-F 24F-2 25 2-E 3 4 40-F 5 6-K 7-M 8-A 8-K 8-M 9-M ABS DD-15E ABS-15G ABS-EE ADV ADV-E ADV-H ADV-NR ADV-W ATS ATS-R BD BD-N BDW C CA-1 CB CFPORTAL D F-1 F-10 F-3 F-4 F-6 F-7 F-8 F-80 F-N F-X ID MA MA-I MA-NR MA-W MSD MSDW n/a N-14 N-17D-1 N-17f-1 N-17f-2 N-18f-1 N-1A N-2 N-23c-3 N-27D-1 N-3 N-4 N-5 N-54A N-54C N-6 N-6EI-1 N-6F N-8A N-8B-2 N-8B-4 N-8F N-CR N-CSR N-MFP N-PX N-Q NRSRO N-SAR PF PILOT R31 S-1 S-11 S-20 S-3 S-4 S-6 S-8 SBSE SBSE-A SBSE-BD SBSE-C SBSE-W SCI SD SDR SE SF-1 SF-3 SIP T-1 T-2 T-3 T-4 T-6 TA-1 TA-2 TA-W TCR TH WB-APP X-17A-19 X-17A-5 Part I X-17A-5 Part II X-17A-5 Part IIA X-17A-5 Part IIB X-17A-5 Part III X-17A-5 Schedule I X-17F-1A Filing Types Include Ownership Filings Exclude Ownership Filings Only Show Ownership FIlings Ownership Filings Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel DateFilerForm TypeView01/10/20255:30 AMIkena Oncology (Subject)Form 42512/31/20242:44 PMBML Investment Partners, L.P. (Filed by)Ikena Oncology (Subject)Form SCHEDULE 13G12/23/20247:37 AMIkena Oncology (Filer)Form 8-KCurrent report pursuant to Section 13 or 15(d) 12/23/20247:40 AMIkena Oncology (Subject)Form 42511/07/20247:00 AMIkena Oncology (Filer)Form 10-QGeneral form for quarterly reports under Section 13 or 15(d) 05/28/20243:24 PMIkena Oncology (Filer)Form 8-KCurrent report pursuant to Section 13 or 15(d) 05/13/20243:33 PMIkena Oncology (Filer)Form 10-QGeneral form for quarterly reports under Section 13 or 15(d) 04/26/20243:22 PMIkena Oncology (Filer)Form DEF 14A03/12/20246:48 AMIkena Oncology (Filer)Form S-8Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans 03/12/20246:30 AMIkena Oncology (Filer)Form 10-KAnnual report pursuant to Section 13 or 15(d) 03/11/20247:19 AMFMR LLC (Filed by)Ikena Oncology (Subject)Form SC 13G/A02/21/20243:29 PMIkena Oncology (Filer)Form 8-KCurrent report pursuant to Section 13 or 15(d) 02/14/20243:57 PMCITADEL ADVISORS LLC (Filed by)Ikena Oncology (Subject)Form SC 13G/A02/14/20248:47 AMBIOTECHNOLOGY VALUE FUND L P (Filed by)Ikena Oncology (Subject)Form SC 13G/A02/09/20248:16 AMIkena Oncology (Subject)Form SC 13G/A02/02/20244:15 PMEcsedy Jeffrey (Reporting)Ikena Oncology (Issuer)Form 4Statement of changes in beneficial ownership of securities 02/02/20244:07 PMIkena Oncology (Issuer)Manfredi Mark (Reporting)Form 4Statement of changes in beneficial ownership of securities 02/02/20244:08 PMIkena Oncology (Issuer)Marango Jotin (Reporting)Form 4Statement of changes in beneficial ownership of securities (Data available from 1/1/2016 forward) Related Companies and Tools Related Companies YMAB 10Q Form VYGR 10Q Form LFVN 10Q Form ITOS 10Q Form AQST 10Q Form IMMP 10Q Form NGNE 10Q Form OLMA 10Q Form ATYR 10Q Form RZLT 10Q Form SEC Filings Tools Latest SEC FilingsInsider Trading Activity This page (NASDAQ:IKNA) was last updated on 1/21/2025 by MarketBeat.com Staff From Our PartnersCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredStunning Trump Exec Order LeakedThis secret document contains stunning details about Donald Trump’s very first order of business… the minute h...Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode in 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredBuy this coin BEFORE Inauguration Day …Mark my words … Bitcoin is going to $100,000. BEFORE Trump is inaugurated. And I think it could reach $1...Weiss Ratings | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowThe crypto bull market is here, and the stakes couldn’t be higher. The next 3-6 months? They’re the most ex...Crypto Swap Profits | SponsoredA deadly mistake in my prediction…I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredElon’s New AI Firm REVEALEDNvidia’s AI chip … the H100 … has been the holy grail of artificial intelligence… Until now. Because Elo...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Ikena Oncology, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Ikena Oncology With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
